TWINBEECH CAPITAL LP - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWINBEECH CAPITAL LP ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$929,129
-63.2%
99,160
-8.6%
0.02%
-64.7%
Q1 2023$2,524,958
-20.8%
108,507
-34.4%
0.05%
-39.3%
Q3 2022$3,190,000
+468.6%
165,460
+658.9%
0.08%
+236.0%
Q1 2022$561,000
-77.0%
21,802
-61.0%
0.02%
-85.5%
Q3 2021$2,436,00055,9740.17%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders